https://www.123articleonline.com/rss/author/466285/curex-bioArticles written by curex bio from 123ArticleOnline.comen-usCopyright (c) 123ArticleOnline.com All rights reserved. https://www.123articleonline.com/articles/1545312/bioequivalence-studies-a-critical-step-for-generic-tablet-approval CurexBio aids in regulatory strategy development, submission preparation, gap assessments, agency response management, and lifecycle maintenance. https://www.123articleonline.com/articles/1544372/clinical-development-services-for-generic-pharmaceuticals Regulatory obligations persist post-product approval. CurexBio provides pharmacovigilance services to assist manufacturers in maintaining compliance through adverse event processing, signal detection, aggregate reporting, risk management, and safety surveillance. https://www.123articleonline.com/articles/1544673/clinical-trial-requirements-for-generic-tablet-and-capsule-manufacturers Data Integrity:ÂRegulatory inspections are emphasizing data integrity practices, with the FDA's April 2024 guidance detailing expectations for data integrity in in vivo bioavailability and bioequivalence studies. All clinical trial studies initiated after December 17, 2016, must submit data in CDISC-compliant format. https://www.123articleonline.com/articles/1542977/how-accurate-clinical-documentation-speeds-regulatory-approvals CurexBio emphasizes the importance of precise clinical documentation for regulatory compliance. Operating as a reputable CRO in India, the USA, and Canada, we offers extensive services aimed at ensuring meticulous document preparation to meet standards. https://www.123articleonline.com/articles/1543974/how-clinical-research-supports-successful-generic-drug-launches Accurate data collection and management are essential for successful submissions, with CurexBio assisting sponsors in ensuring data integrity, database validation, query management, data cleaning, and regulatory compliance. https://www.123articleonline.com/articles/1543199/the-role-of-cro-services-in-oral-solid-dosage-osd-development CurexBio's Regulatory Affairs team has expertise in major entities like the FDA, EMA, DCGI, and NMPA, offering support from pre-submission to IND and NDA submissions. https://www.123articleonline.com/articles/1545416/top-10-bioanalytical-challenges-that-delay-drug-development Whether you are developing a small molecule, biologic, biosimilar, vaccine, or next-generation therapy, CurexBio provides end-to-end bioanalytical support tailored to your program's unique requirements.